Payment of tradable shares by Peter Wilkinson of Laboratory subject to Rule 16b-3
| MFC-PJ Preferred Stock | CAD 23.80 0.05 0.21% |
About 62% of Manulife Fin's investor base is looking to short. The analysis of current outlook of investing in Manulife Fin Non suggests that many traders are alarmed regarding Manulife Fin's prospects. The current market sentiment, together with Manulife Fin's historical and current headlines, can help investors time the market. In addition, many technical investors use Manulife Fin Non preferred stock news signals to limit their universe of possible portfolio assets.
Manulife |
Filed transaction by Laboratory Corp Of Americ officer. Payment of exercise price or tax liability by delivering or withholding securities
Read at macroaxis.com
Manulife Fin Fundamental Analysis
We analyze Manulife Fin's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Manulife Fin using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Manulife Fin based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Short Ratio
Short Ratio Comparative Analysis
Manulife Fin is currently under evaluation in short ratio category among its peers. Short Ratio is typically used by traders and speculators to identify trends in current market sentiment for a particular equity instrument. In its simple terms this ratio shows how many days it will take all current short sellers to cover their positions if the price of a stock begins to rise.
Manulife Fin Non Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Manulife Fin preferred stock to make a market-neutral strategy. Peer analysis of Manulife Fin could also be used in its relative valuation, which is a method of valuing Manulife Fin by comparing valuation metrics with similar companies.
Peers
Manulife Fin Related Equities
| CVS | CVS HEALTH | 1.84 | ||||
| DHT-U | DRI Healthcare | 0.58 | ||||
| RHT | Reliq Health | 0.00 | ||||
| AC | Air Canada | 0.20 | ||||
| LIO | Lion One | 3.33 | ||||
| QCCU | QC Copper | 7.69 |
Complementary Tools for Manulife Preferred Stock analysis
When running Manulife Fin's price analysis, check to measure Manulife Fin's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Manulife Fin is operating at the current time. Most of Manulife Fin's value examination focuses on studying past and present price action to predict the probability of Manulife Fin's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Manulife Fin's price. Additionally, you may evaluate how the addition of Manulife Fin to your portfolios can decrease your overall portfolio volatility.
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |